Eli Lilly LLY vs. Novo Nordisk NOVO: The pros weigh in on weight-loss stocks
Shares in Eli Lilly are up around 60% year-to-date, while Novo Nordisk has gained around 50%. Should investors buy either stock — or both?
Source: cnbc.com
Stay updated with breaking news from Eli Lilly With. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares in Eli Lilly are up around 60% year-to-date, while Novo Nordisk has gained around 50%. Should investors buy either stock — or both?